Back

Impact of epicardial adipose tissue and atrial functional impairment in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement

31 August 2024 (16:09 - 16:21)
Organised by: Logo
Congress Presentation Part of: Exploring valvular and congenital heart disease with cardiac magnetic resonance Morphology, Dimensions, Volumes and Mass ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Judith Gronwald

University Medical Centre of Gottingen (UMG), Goettingen (Germany)

4 More presentations in this session

Presentation thumbnail
Severe aortic stenosis is associated with left atrial prothrombotic flow changes that persists despite successful aortic valve replacement
Doctor M. Spartera (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Right atrial and ventricular function in risk stratification of patients with pulmonary artery hypertension
Miss J. Guo (Sichuan, CN)
Abstract Slides Video
Presentation thumbnail
LV reverse remodeling after SAVR in patients with severe symptomatic aortic stenosis: impact on the clinical outcome
Doctor M. Lima (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Fenofibrate modulates cardiac energy metabolism in moderate-severe aortic stenosis: a mechanistic double-blinded randomised controlled MR trial
Doctor S. Monga (Oxford, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Exploring valvular and congenital heart disease with cardiac magnetic resonance
Video

The Event

Event poster

ESC Congress 2024

31 August 2024 16:09 CET
You may be interested in
thumbnail
Congress Presentation
Epicardial adipose tissue volumes for long-term risk stratification in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement
thumbnail
Congress Session
Exploring valvular and congenital heart disease with cardiac magnetic resonance
thumbnail
Congress Presentation
Pathophysiological role of epicardial adipose tissue and its phenotypes in patients with diabetes and cardiovascular comorbidities.

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources